Macrophages and CNS remyelination.

Area of Science:

• Neuroimmunology
• Cellular Biology
• Regenerative Medicine

Background:

• Microglia are the primary immune cells in the central nervous system (CNS).
• Both resident microglia and circulating monocytes contribute to CNS inflammation and repair.
• Microglia/macrophages have demonstrated critical roles in the CNS regenerative process of remyelination.

Purpose of the Study:

• To review the roles of microglia, monocytes, and their derived macrophages in creating lesion environments conducive to remyelination.
• To highlight the specific functions of M1 (cytotoxic) and M2 (regenerative) activation phenotypes.
• To examine how aging affects the pro-regenerative capacity of the innate immune system in the CNS.

Main Methods:

• Literature review of studies on microglia, monocytes, and macrophages in CNS injury and repair.
• Analysis of the functional dichotomy of microglia/macrophage activation states (M1 vs. M2).
• Examination of the impact of aging on immune cell-mediated remyelination.

Main Results:

• Microglia and macrophages exhibit distinct activation phenotypes (M1/M2) influencing CNS lesion environments.
• M2 macrophages are associated with pro-regenerative processes, including remyelination.
• Aging can alter the balance of these phenotypes, potentially impairing the regenerative capacity of the innate immune system.

Conclusions:

• Microglia and macrophages are key players in CNS repair, with their activation states dictating outcomes.
• Understanding M1/M2 phenotypes is crucial for developing strategies to promote remyelination.
• Age-related changes in the innate immune system present a significant challenge for CNS regeneration.